5th Annual Orphan Drugs and Rare Diseases Event

Following the success of previous events, SMi's 5th annual conference on Orphan Drugs returns to London this Autumn.
With a focus on the latest regulatory developments and strategies for best route to market, the conference will explore how payers, pharmaceutical, biotech and patient organisations are preparing to participate in and leverage the growing orphan drugs and rare diseases industry. Featured speakers include MHRA, Chiesi Pharma, NICE, Alexion Pharma, Mereo BioPharma, and more.

Why You Should Attend Orphan Drugs :
• Explore the development of orphan drugs and how they prevent, diagnose and treat rare diseases
• Understand the industry with a focus on emerging markets and partnering with venture capitals
• Discuss the role of patient associations and how they are helping to fund the rare diseases field
• Learn strategies on defending the pricing of orphan products and how to establish a foundation for reimbursement
• Discover a new business model for developing rare diseases treatments
• Plus Two Interactive Pre-Conference Workshops : Developing the optimal orphan drug development strategy Hosted by Cell Medica and Chiesi Farmaceutici

Price :
Early Bird: Book by 30 September: GBP 1399
Standard Price: GBP 1499
1 Workshop: GBP 599
2 Workshops: GBP 1198
Early Bird: Book by 31 August: GBP 1299

Speakers: MHRA, Abeona, Alexion, NICE, Mereo BioPharma, Tikomed